500
Participants
Start Date
July 31, 2002
Primary Completion Date
September 30, 2004
Study Completion Date
September 30, 2004
MERREM I.V. 2g as a 3 hour infusion every 8 hours
vancomycin I.V. 1 g every 12 hours
tobramycin I.V. 5 mg/kg every 24 hours
MERREM I.V. 1g as a 30 minute infusion every 8 hours
MERREM I.V. 500 mg as a 3 hour infusion every 8 hours
Phoenix
Newark
Indianapolis
Boston
Lebanon
Albany
New York
Stony Brook
Cincinnati
San Antonio
Lead Sponsor
Pfizer
INDUSTRY